Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/en/publikationen/7653-safety-immunogenicity-and-preliminary-clinical-efficacy-of-a-vaccine-against-extraintestinal-pathogenic-escherichia-coli-in-women-with-a-history-of-recurrent-urinary-tract-infection-a-randomised-single-blind-placebo-controlled-phase-1b-trial